2000
DOI: 10.1002/1521-4141(200007)30:7<1919::aid-immu1919>3.0.co;2-3
|View full text |Cite
|
Sign up to set email alerts
|

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

18
208
1

Year Published

2001
2001
2011
2011

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 249 publications
(227 citation statements)
references
References 38 publications
18
208
1
Order By: Relevance
“…Recovery numbers of HL were also increased by day 4 of L. monocytogenes infection and slightly, though not significantly, elevated by a-GalCer treatment (data not shown). Consistent with previous findings [57][58][59][60][61][62][63][64][65], a-GalCer/CD1d tetramer-reactive (a-GalCer/CD1d 1 ) T cells became undetectable on day 1 after a-GalCer treatment and then re-emerged, though incompletely, by day 4 ( Fig. 2A, Table 1).…”
Section: Monocytogenes-induced Inflammation In the Liver And Spleesupporting
confidence: 92%
“…Recovery numbers of HL were also increased by day 4 of L. monocytogenes infection and slightly, though not significantly, elevated by a-GalCer treatment (data not shown). Consistent with previous findings [57][58][59][60][61][62][63][64][65], a-GalCer/CD1d tetramer-reactive (a-GalCer/CD1d 1 ) T cells became undetectable on day 1 after a-GalCer treatment and then re-emerged, though incompletely, by day 4 ( Fig. 2A, Table 1).…”
Section: Monocytogenes-induced Inflammation In the Liver And Spleesupporting
confidence: 92%
“…Interestingly, a recent report by Chisari and colleagues (31) found that the activation of NKT cells in HBV transgenic mice in vivo by ␣-GalCer (a glycolipid that is presented by CD1d1 to NKT cells) (8,9,12,33) caused the rapid loss of NKT cells, recruited NK cells, and inhibited HBV replication in the mice in an IFN-␣/␤-and IFN-␥-dependent manner (31). Others have also seen such a reduction in liver NKT cells following treatment of mice with ␣-GalCer (19,43,48) or anti-CD3 (18) and have reported a role for NKT-cell-produced IFN-␥ in the induction of NK cell activity (13,19). In the case of LCMV, we have found that the virus-induced NK cell activity is actually normal in an NKT-cell-deficient environment (i.e., CD1d1-deficient mice) (57), and LCMV infection also resulted in the loss of NKT cells in IFN-␥-deficient mice (Table 1).…”
Section: Discussionmentioning
confidence: 91%
“…NKT cell differentiation towards a Th1 or Th2 direction was often unpredictable [62]. NKT cells are less frequent in humans than they are in mice [2], and high doses of a-GalCer have caused severe liver damage in mice [63]. Furthermore, there is evidence that in the absence of cognate antigen, NKT cells restrain the anti-tumour activity of CpG ODN in mice [64].…”
mentioning
confidence: 99%